Neurodegeneration Meets Neuroregulation: Cannabinoids, ALS, and the Endocannabinoid System

Time: June 3rd, Noon PM EST        

Location – Virtual Meeting
https://us02web.zoom.us/j/83722922366?pwd=QjZ3V0xNWHZ0OVZ0b3BpbWd3STRqUT09

Event Description:

In this journal club, we’ll explore the emerging clinical implications of cannabinoids in the treatment of Amyotrophic Lateral Sclerosis (ALS), drawing from a recent article published in Muscle & Nerve by Denton et al. (2025). We’ll examine how cannabinoid signaling intersects with ALS pathophysiology and what this could mean for therapeutic development. The article offers a synthesis of preclinical and clinical findings and evaluates current gaps in research and care.

Featured Article:

Denton, T. T. et al. Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications. Muscle Nerve (2025) doi:10.1002/mus.28359.

Speakers:

• Phil Molloy, MD – Clinical education expert

• Teresa Simon, MPH – Public health epidemiologist

• Len Kamen, MD – Clinical pain specialist

• Jahan Marcu, PhD – Cannabis researcher

Questions? Email Prctrials.info@gmail.com

This journal is supported by PRC+. PRC + has education modules and other resources available for health care professionals: https://www.prc-trials-plus.com/education